Rupert Soames Acquires 5,344 Shares of Smith & Nephew plc (LON:SN) Stock

Smith & Nephew plc (LON:SN) insider Rupert Soames acquired 5,344 shares of Smith & Nephew stock in a transaction dated Monday, November 11th. The shares were acquired at an average price of GBX 936 ($12.04) per share, with a total value of £50,019.84 ($64,367.31).

Smith & Nephew Price Performance

Shares of SN opened at GBX 956.20 ($12.30) on Thursday. The stock has a 50 day moving average price of GBX 1,105.42 and a 200-day moving average price of GBX 1,077.91. The firm has a market capitalization of £8.34 billion, a PE ratio of 3,541.48, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reiterated a “buy” rating and issued a £145 ($186.59) target price on shares of Smith & Nephew in a report on Monday, August 5th. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Smith & Nephew presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 3,956.20 ($50.91).

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.